Jonathan Silverstein
Chairman at Enobia Pharma, Inc.
Network origin in Jonathan Silverstein first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
102
| Subsidiary | Investment Managers | 102 |
University of San Diego
80
| College/University | Other Consumer Services | 80 |
Denison University
54
| College/University | Other Consumer Services | 54 |
| Subsidiary | Pharmaceuticals: Major | 35 | |
| Public Company | Pharmaceuticals: Major | 31 | |
| Public Company | Pharmaceuticals: Major | 29 | |
29
| Subsidiary | Pharmaceuticals: Major | 29 |
| Extinct | Biotechnology | 21 | |
| Subsidiary | Biotechnology | 20 | |
| Public Company | Medical Specialties | 17 | |
| Subsidiary | Electronic Equipment/Instruments | 13 | |
| Public Company | Medical Specialties | 12 | |
| Subsidiary | Medical Specialties | 5 | |
| Public Company | Pharmaceuticals: Major | 4 | |
DFINE, Inc.
 DFINE, Inc. Medical SpecialtiesHealth Technology DFINE, Inc.engages in the development and commercialization of medical device system for treating vertebral compression fractures. The company was founded by John H. Shadduck and Csaba Truckai in 2004 and is headquartered in South Jordan, UT.
4
| Subsidiary | Medical Specialties | 4 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Predix Pharmaceuticals, Inc. develops novel drugs and other related products. It is a clinical stage drug development company that uses proprietary discovery and lead optimization engine to develop novel drugs for G-protein coupled receptor (GPCR) and ion channel targets. The company was founded by Silvia Noiman, Haim Aviv, Oren M. Becker and Oren M. Ramot in September, 2002 and is headquartered in Woburn, MA.
2
| Extinct | Pharmaceuticals: Major | 2 |
Arteaus Therapeutics LLC
 Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA.
2
| Private Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jonathan Silverstein via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Chief Executive Officer Founder Founder Analyst-Equity Corporate Officer/Principal Analyst-Equity Portfolio Manager-Fixed Income Trading-Equity | |
| TRICIDA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Chairman Corporate Officer/Principal | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Director/Board Member Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Chairman Chief Executive Officer Founder Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Treasurer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| New York University | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| GELESIS INC | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
| Harvard Business School | College/University | Doctorate Degree Masters Business Admin Masters Business Admin | |
| THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| University of Michigan | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Consultant / Advisor | |
| The University of Chicago | College/University | Masters Business Admin Undergraduate Degree | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Investor Relations Contact | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
| Brigham Young University | College/University | Graduate Degree Graduate Degree | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| FORTRESS INVESTMENT GROUP LLC | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| University of Florida | College/University | Undergraduate Degree Doctorate Degree | |
MC10, Inc.
 MC10, Inc. Medical SpecialtiesHealth Technology MC10, Inc. develops stretchable silicon materials for the microelectronics industry. The firm's technology uses semiconductors in conjunction with interconnect and packaging technologies to produce conformal electronics. It offers solutions for applications in consumer electronics, medical devices, industrial products, defense systems, differentiated consumer products, industrial, and military markets. The company was founded by Carmichael S. Roberts Jr., John A. Rogers, Benjamin Schlatka, Marvin J. Slepian, George M. Whitesides, Gilman Callsen and Roozbeh Ghaffari in 2008 and is headquartered in Lexington, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| Recardia Therapeutics, Inc. | Director/Board Member President | ||
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| United States | 48 |
| Switzerland | 3 |
| Ireland | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 14 |
| Finance | 6 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 653 |
| Independent Dir/Board Member | 200 |
| Corporate Officer/Principal | 198 |
| Chairman | 128 |
| Chief Executive Officer | 105 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Robert More | 42 |
| Stephen P. Squinto | 40 |
| Louis Lange | 35 |
| Scott Rocklage | 32 |
| Kush Parmar | 32 |
| Russell C. Hirsch | 31 |
| Joseph Zakrzewski | 30 |
| Jay Shepard | 30 |
| Erez Chimovits | 30 |
| Sunny Sharma | 29 |
| Rishi Gupta | 29 |
| Olav Bergheim | 28 |
| Guo-Liang Yu | 27 |
| David Bonita | 27 |
- Stock Market
- Insiders
- Jonathan Silverstein
- Company connections
